Company Overview and News

0
Innovation to feed the world

2h nzherald.co.nz
It is estimated that New Zealand's agricultural sector can feed 40 million people. At a time where we are seeing an ever-increasing number of alternative meat products — such as the plant-based Impossible Burger that claims to "bleed, sear, and taste like meat" (and recently landed Air New Zealand in controversy) — there is an opportunity for New Zealand to export high-quality, high-value food with a focus on provenance to the world.
ANZLY AIR ANZFF ANZFY AIZ

0
Sowing new seeds

2h nzherald.co.nz
Damien O'Connor is shaking up old thinking on agri-food with his ginger group, he tells Fran O'Sullivan.
ANZLY AIR ANZFF ANZFY AIZ

0
Newcastle to New Zealand flights to begin from November

15h abc.net.au
New South Wales will soon have a second gateway to New Zealand, with three new flights per week from Newcastle set to start later this year.
ANZLY AIR ANZFF ANZFY AIZ

0
Virgin Australia launches Newcastle-Auckland services in escalating battle with Air NZ

15h nzherald.co.nz
The airline will fly three times a week to the New South Wales coastal city between November and February next year.
ANZLY AIR ANZFF ANZFY AIZ

0
United Airlines leads the pack with extra charges

17h nzherald.co.nz
One ultra-low-cost carrier in the United States makes 47 per cent out of ''dynamic pricing'' of seats, bags and bundled offers, according to new research.
ANZLY AIR ANZFF ANZFY AIZ

0
Singapore Airlines triumphs in Skytrax Awards

2018-07-17 nzherald.co.nz
Singapore Airlines has been voted the world's best airline by travellers, with Qatar Airways taking second place and Japan's ANA in third position.
ZNH C6L ANZLY AIR ANZFF SINGY ANZFY AIZ SINGF 1055

2
Growth Slows For Southwest Ahead Of 2nd Quarter Earnings Report

2018-07-16 seekingalpha
Southwest Airlines reported year-over-year June 2018 traffic with revenue passenger miles increasing 2.6% in addition to available seat miles increasing 3.2% year over year.
JAPSY C6L AIR HA JBLU SINGY ANZFY AIZ ANZLY BOE ANZFF BA DAL SINGF

0
Virgin Australia Adds Seasonal Flights To Short-Haul Routes

2018-07-13 aviationweek
AUCKLAND—Virgin Australia is boosting its flight schedule on short-haul international routes to New Zealand and the Pacific Islands over the southern summer peak season. The scale of the seasonal flights is similar to what the carrier has operated in previous years. However, it also provides more evidence that the airline will compete strongly in the Australia-New Zealand market following the breakup of its partnership with Air New Zealand at the end of October.
ANZLY AIR ANZFF ANZFY AIZ

0
Fran O'Sullivan: Changing attitudes as companies take on emission targets

2018-07-13 nzherald.co.nz
Cynics will inevitably label the embrace of the Government's Zero Carbon zeitgeist by top business and farming leaders as "virtue signalling" at its worst.
ZNZ ANZLY SKC AIR ZNRGF ANZFF ANZFY ZEL AIZ

0
Virgin Australia adds transtasman flights after bust-up with Air New Zealand

2018-07-13 nzherald.co.nz
Virgin Australia will add more seats across the Tasman over summer as its alliance with Air New Zealand ends.
ANZLY AIR ANZFF ANZFY AIZ

0
Farmlands takes honours in survey of Kiwi brands

2018-07-12 nbr.co.nz
The Farmlands Co-operative Society has emerged as the top New Zealand brand in a KPMG survey that asked customers of different countries to rate brands on various criteria related to customer experience.
CEN FBU AIR FCREY FRCEF ANZFY COENY AIZ COENF FBU ANZLY CEN ANZFF

0
Air New Zealand, JetBlue Form Technology Partnership

2018-07-12 aviationweek
Air New Zealand will partner with JetBlue Airways subsidiary JetBlue Technology Ventures (JTV) to support the development of new technology in the travel industry. JTV and Air New Zealand said they will “work together to build an internationally recognized technology innovation ecosystem that will seek out, partner and implement emerging technologies in the travel sector.” Air New Zealand said the initiative will offer it early access to emerging technologies, and entry to the .
ANZLY AIR JBLU ANZFF ANZFY AIZ

0
NZ shares drop as A2 weakens on trading update

2018-07-12 nzherald.co.nz
New Zealand shares fell, led lower by A2 Milk Co and Sky Network Television, while Kathmandu Holdings hit a four-and-a-half year high.
KTHDY WBC AIR WEBNF WBK ANZFY AIZ KMD SKT SYKWF WBC ANZLY SKKTY ANZFF KMD

0
NZ businesses sign up to action against climate change

2018-07-12 radionz.co.nz
Chief executives of 60 companies, including Air New Zealand, Fonterra, Spark, Westpac, Freightways, Ports of Auckland and KiwiRail, have formed the Climate Leaders Coalition and committed their companies to action.
ZNZ ANZLY AIR ZNRGF ANZFF ANZFY ZEL AIZ

0
Air New Zealand partners with JetBlue Technology Ventures in Silicon Valley

2018-07-12 nzherald.co.nz
Air New Zealand has entered a partnership with the innovation arm of United States airline JetBlue Airways that has already invested in flying cars and electric planes.
ANZLY AIR JBLU ANZFF ANZFY AIZ

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

CUSIP: 009136102